BioCentury
ARTICLE | Clinical News

Atrovent HFA regulatory update

November 22, 2004 8:00 AM UTC

FDA approved Atrovent HFA inhalation aerosol, a reformulation of Atrovent (CFC), for bronchospasm associated with chronic obstructive pulmonary disease (COPD), including chronic bronchitis and emphyse...